Markets & Finance

Movers: U.S. Steel, Emcor, Netflix, Nike, Dow Jones


Plus: Imclone, Nucor, and more stocks making headlines Monday

From Standard & Poor's Equity ResearchU.S. Steel (X)

Down 5.68 to 119.37

Seen lower on report ThyssenKrupp AG said it isn't in talks with U.S. STEEL or Russia's OA Severstal.

Emcor Group (EME)

Up 4.57 to 69.25

Raises 2007 revenue guidance to $5.5B-$5.7B, EPS to $2.75-$3.00. The company cites continuing indications of strong demand patterns within many of its markets, particularly in commercial, healthcare, gaming, hospitality.

Netflix (NFLX)

Down 0.98 to 22.45

JP Morgan downgrades to underweight from neutral.

NIKE (NKE)

Up 0.68 to 53.64

HSBC upgrades to overweight from neutral, raises target price to $64 from $52.50.

Dow Jones (DJ)

Down 0.32 to 60.10

According to a Wall Street Journal report, General Electric GE, Microsoft (MSFT) discussed combining Dow Jones with some parts of NBC/Universal, parrying News Corp. (NWS), but the parties couldn't reach agreement.

Imclone Systems (IMCL)

Up 0.17 to 38.39

The company and Bristol Myeres Squibb (BMY) say the FDA accepted a supplemental biologics license application for Erbitux which seeks to include evidence of improved overall survival in labeling in third-line treatment of patients with metastatic colorectal cancer.

Illumina (ILMN)

Up 1.65 to 37.00

Announces launch of iControlDB, first industry-hosted genotyping control repository available for immediate use by researchers conducting case-control whole-genome association studies.

Universal Electronics (UEIC)

Up 2.50 to 34.65

WR Hambrecht reportedly upgrades to buy from hold.

Varian Medical (VAR)

Up 1.16 to 41.92

CIBC World upgrades to sector outperform from sector perform. The company was unavailable for comment.

Nucor (NUE)

Down 4.04 to 62.57

Expects second quarter EPS to be in range of $1.05-$1.15. The company says earnings were significantly impacted by lower shipments of the company's bar mill group.

Medivation (MDVN)

Up 4.10 to 20.28

The company says benefits of its Dimebon drug over placebo in Phase 2 study in mild-to-moderate Alzheimer's disease were statistically significant on all 5 endpoints at 12 months. Rodman & Renshaw maintains market perform.

Back Yard Burger (BYBI)

Up 1.16 to 6.21

Agrees to be acquired by BBAC, LLC in a $38 million deal, which includes debt to be repaid by BBAC. Terms: $6.50 per Back Yard share in cash.

Peru Copper (CUP)

Up 0.19 to 6.16

Agrees to be acquired by Aluminum Corp. Of China in a C$840 million deal. Terms: C$6.60 per CUP share in cash.

Affiliated Computer Services (ACS)

Up 1.49 to 59.75

Inks a deal with company chairman Darwin Deason and Cerberus Capital Management to suspend Exclusivity Agreement between Deason and Cerberus so that ACS can consider a sale of itself. that it considers to be in best interests of the company and its shareholders.


Hollywood Goes YouTube
LIMITED-TIME OFFER SUBSCRIBE NOW

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

 
blog comments powered by Disqus